Director at Moderna (NASDAQ: MRNA) granted 8,371 restricted stock units

Q: How many restricted stock units did the Moderna (MRNA) director receive?

The director received 8,371 restricted stock units . Each unit is linked to one share of Moderna common stock, so this grant represents potential future ownership of 8,371 shares, subject to vesting and continued service requirements.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Moderna, Inc. director Elizabeth E. Tallett received a grant of 8,371 restricted stock units on May 6, 2026. Each restricted stock unit converts into one share of Moderna common stock.

The 8,371 units will vest in full on the earlier of May 6, 2027 or Moderna's next Annual Meeting of Shareholders, as long as she continues serving the company. Following this grant, her reported direct holding from this award is 8,371 restricted stock units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Tallett Elizabeth E

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	8,371	$0.00	--

Holdings After Transaction: Restricted Stock Units — 8,371 shares (Direct, null)

Footnotes (1)

Restricted stock units convert into common stock on a one-for-one basis. The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

Key Figures

RSUs granted: 8,371 units Post-grant RSU holdings: 8,371 units Conversion ratio: 1 RSU = 1 share +1 more

4 metrics

RSUs granted 8,371 units Restricted stock unit award on May 6, 2026

Post-grant RSU holdings 8,371 units Total restricted stock units following transaction

Conversion ratio 1 RSU = 1 share Restricted stock units convert into common stock one-for-one

Vesting date trigger May 6, 2027 Full vesting or earlier at next Annual Meeting of Shareholders

Key Terms

Restricted Stock Units, vest, Annual Meeting of Shareholders

3 terms

Restricted Stock Units financial

"Restricted stock units convert into common stock on a one-for-one basis."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest financial

"The shares subject to this restricted stock unit award will vest in full"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Annual Meeting of Shareholders financial

"on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Form 4 Insider Transactions: What Each Field Means →

05/08/2026 - 04:57 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tallett Elizabeth E

(Last)

(First)

(Middle)

C/O MODERNA, INC.

325 BINNEY STREET

(Street)

CAMBRIDGE

MASSACHUSETTS

02142

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Moderna, Inc. [ MRNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	05/06/2026		A		8,371		⁽²⁾	⁽²⁾	Common Stock	8,371	$0	8,371	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

	/s/ James Dillon, as Attorney-in-Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Moderna (MRNA) director Elizabeth Tallett report on this Form 4?

Elizabeth E. Tallett reported receiving 8,371 restricted stock units from Moderna, Inc. as a grant. These units are reported as a direct holding and represent compensation in equity form rather than a market purchase of common stock.

How many restricted stock units did the Moderna (MRNA) director receive?

The director received 8,371 restricted stock units. Each unit is linked to one share of Moderna common stock, so this grant represents potential future ownership of 8,371 shares, subject to vesting and continued service requirements.

When do Elizabeth Tallett’s Moderna (MRNA) restricted stock units vest?

The 8,371 restricted stock units will vest in full on the earlier of May 6, 2027, or Moderna’s next Annual Meeting of Shareholders. Vesting is conditioned on the recipient’s continued service to Moderna through that vesting date.

Do the Moderna (MRNA) restricted stock units automatically convert into common stock?

Yes. The filing states that restricted stock units convert into Moderna common stock on a one-for-one basis. After vesting, each unit becomes one share of common stock, giving the holder direct equity exposure in the company.

What is Elizabeth Tallett’s Moderna (MRNA) holding after this restricted stock unit grant?

After this transaction, the reported direct holding from this award is 8,371 restricted stock units. This matches the number of units granted in the filing and reflects her position in this specific equity award following the grant.